Lexicon Likely Looking At Even More Competition In Type 1 Diabetes | Latest News RSS feed

Lexicon Likely Looking At Even More Competition In Type 1 Diabetes - Latest News


Lexicon Likely Looking At Even More Competition In Type 1 Diabetes

Data from Phase III trials of Lilly/Boehringer's Jardiance in Type 1 diabetes supports submission and commercialization, bringing another competitor into the market. Lexicon's sotagliflozin is not out ... read more

Using The Past To Predict The Future For Local Search

Now, there is much more competition ... weren’t even considered in the early surveys — e.g., social, user behavior, personalization, etc. Even the word “citation,” which is regularly used in today’s l... read more

Blizzard Questions, Including Why a European Weather Model (Usually) Excels at U.S. Forecasts

With a likely gap ... to the same or even better tools (maps, weather data) that trained forecasts in real-time. The Euro and GFS have become part of the public lexicon just like the Polar Vortex and ... read more

Looking for another news?


Snowboarding 101: Origins and Olympic history

The competition scene ... have at least one — most likely two — triples in their run in order to win gold. For that reason, Canadian shredders Mark McMorris and Max Parrot were seen as favorites. But ... read more


25 Lessons We've Learned in The Motley Fool's 25 Years

Disruptive companies usually look like underdogs at the outset. They're taking on entrenched interests with far more resources ... they likely would have made impressive money -- 10 times their origin... read more

Lexicon Likely Stuck For A Little While

In the case of Lexicon Pharmaceuticals (NASDAQ:LXRX), a seemingly good initial launch of its first drug Xermelo is being greeted with little more than a "oh ... non-insulin options in Type 1 diabetes. ... read more

Mark Levinson No 533H Multi-Channel Amplifier Reviewed

Comparing the No 533H to, say, an Emotiva MPS-2 priced at $1,699 is a bit like comparing apples to oranges because of price and channels, but many today are looking for more budget conscious ... it co... read more

Barbie Has a New Body Cover Story

Barbie is more than just a doll. The brand does $1 billion in sales ... it is we do this. Over time I would love it if a girl wouldn’t snicker and just think of it as another beautiful doll.” It’s a s... read more

3 Top Biotech Stocks to Buy in December

That likely ... to type 1 and 2 diabetics. Lexicon also has some much-needed help along the way. It's partnered with Sanofi(NYSE: SNY) to help develop sotagliflozin. Lexicon is primarily handling the ... read more

Why the Reluctance to Use Biosimilar Insulins for Diabetes?

Staff costs are involved in moving patients to a new insulin, and in the case of patients with type 1 diabetes, they may be using technology such as insulin pumps, which makes swapping products even m... read more

8 Things You Didn't Know About Diabetes

Even ... Type 1. Some red flags indicating an older person with Type 2 may have Type 1: Her weight is normal and she doesn’t respond to Type 2 medications. 5. It really hurts your heart. People with d... read more

Investing in Diabetes Stocks: A Beginner's Guide

The numbers get even more ... Type 1 diabetes and gestational diabetes require treatment. Most patients with Type 2 diabetes receive regular care as well. Here's an overview of the tools and methods t... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us